Due to its effects on hepatic oxidative capacity, circulating TG and free fatty acid levels, LPIN-1 has been suggested as a potential therapeutic target for obesity-related dyslipidaemia and NAFLD [30]. Here, LPIN1 is linked to inherited lipid metabolism disorder.